A Study to Learn More About How Drug Aflibercept Works in Canadian Patients With Reduced Vision Caused by New Blood Vessels Growing in the Eye (Myopic Choroidal Neovascularization or mCNV)
Clinical trial NCT04524910 · COMPLETED
Trial details
- NCT number
- NCT04524910
- Sponsor
- Bayer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-06-16
- Primary completion
- 2022-10-17
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.